ACLARIS THERAPEUTICS INC. - COMMON STOCK
1.3600
03-5月-24 14:59:59
15 分の遅延
株式
+0.0500
+3.82%
本日の幅
1.3100 - 1.4000
ISIN
N/A
ソース
NASDAQ
-
18 9 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Corporate Update
07 8 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
13 6 2023 10:09:02 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in Two June Healthcare Investor Conferences
02 6 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics Reports First Quarter 2023 Financial Results and Provides a Corporate Update
08 5 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Announce First Quarter 2023 Financial Results on May 8, 2023
02 5 2023 06:01:12 提供 Nasdaq GlobeNewswire
-
27 3 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
06 3 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
23 2 2023 06:00:01 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in the Virtual SVB Securities Global Biopharma Conference
09 2 2023 15:01:00 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics Provides 2023 Outlook
06 1 2023 06:01:00 提供 Nasdaq GlobeNewswire
-
29 11 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics Announces Key Leadership Transitions
22 11 2022 15:01:00 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in Two November Healthcare Investor Conferences
10 11 2022 15:01:00 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
08 11 2022 06:00:03 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics Appoints Robert Doody as Vice President, Investor Relations
27 9 2022 06:00:24 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
30 8 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
03 8 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics Expands Leadership Team
27 6 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in the Jefferies Healthcare Conference
01 6 2022 15:01:00 提供 Nasdaq GlobeNewswire